

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.60373492 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.57202143 |
| 3 | vocalization behavior (GO:0071625) | 4.36041065 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.29241609 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.19202259 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.12056255 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.11230731 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.09912835 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.07590171 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.03999740 |
| 11 | protein localization to synapse (GO:0035418) | 3.92016436 |
| 12 | synaptic vesicle exocytosis (GO:0016079) | 3.89346879 |
| 13 | cell migration in hindbrain (GO:0021535) | 3.85105996 |
| 14 | layer formation in cerebral cortex (GO:0021819) | 3.80873426 |
| 15 | neuron recognition (GO:0008038) | 3.74083972 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.73480713 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.69821730 |
| 18 | axonal fasciculation (GO:0007413) | 3.61542778 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 3.60368651 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 3.54195713 |
| 21 | dendritic spine morphogenesis (GO:0060997) | 3.51273354 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 3.51087133 |
| 23 | glutamate secretion (GO:0014047) | 3.48604667 |
| 24 | exploration behavior (GO:0035640) | 3.47748654 |
| 25 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46429665 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.45781899 |
| 27 | neuronal ion channel clustering (GO:0045161) | 3.33554630 |
| 28 | postsynaptic membrane organization (GO:0001941) | 3.30706941 |
| 29 | regulation of vesicle fusion (GO:0031338) | 3.26935345 |
| 30 | neurotransmitter secretion (GO:0007269) | 3.26356214 |
| 31 | cell communication by electrical coupling (GO:0010644) | 3.25037291 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.21655589 |
| 33 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14648620 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12730781 |
| 35 | neuronal action potential propagation (GO:0019227) | 3.07387197 |
| 36 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06679256 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.06003116 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 3.04255207 |
| 39 | dendrite morphogenesis (GO:0048813) | 3.03887132 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.03855576 |
| 41 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.01535653 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.01367343 |
| 43 | presynaptic membrane organization (GO:0097090) | 3.01328968 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99953153 |
| 45 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.99123464 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96037585 |
| 47 | response to pheromone (GO:0019236) | 2.92576547 |
| 48 | transmission of nerve impulse (GO:0019226) | 2.91369664 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.88623130 |
| 50 | membrane depolarization during action potential (GO:0086010) | 2.87694245 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 2.83745068 |
| 52 | synaptic vesicle endocytosis (GO:0048488) | 2.81502729 |
| 53 | establishment of mitochondrion localization (GO:0051654) | 2.80640475 |
| 54 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.78794806 |
| 55 | presynaptic membrane assembly (GO:0097105) | 2.78411990 |
| 56 | long-term memory (GO:0007616) | 2.74987288 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 2.72229449 |
| 58 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.71673926 |
| 59 | positive regulation of membrane potential (GO:0045838) | 2.71361974 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 2.69948225 |
| 61 | neurotransmitter transport (GO:0006836) | 2.69162350 |
| 62 | neuromuscular process controlling balance (GO:0050885) | 2.69045871 |
| 63 | membrane hyperpolarization (GO:0060081) | 2.68469891 |
| 64 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.68042803 |
| 65 | membrane depolarization (GO:0051899) | 2.67795101 |
| 66 | auditory behavior (GO:0031223) | 2.67233298 |
| 67 | establishment of nucleus localization (GO:0040023) | 2.66710139 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 2.65727214 |
| 69 | positive regulation of synapse assembly (GO:0051965) | 2.63829870 |
| 70 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.62331330 |
| 71 | positive regulation of dendritic spine development (GO:0060999) | 2.61608213 |
| 72 | activation of protein kinase A activity (GO:0034199) | 2.61423271 |
| 73 | innervation (GO:0060384) | 2.61246795 |
| 74 | synapse assembly (GO:0007416) | 2.60663969 |
| 75 | sodium ion export (GO:0071436) | 2.60551212 |
| 76 | neuromuscular synaptic transmission (GO:0007274) | 2.60261727 |
| 77 | regulation of synapse maturation (GO:0090128) | 2.59620472 |
| 78 | synapse organization (GO:0050808) | 2.59411137 |
| 79 | adult walking behavior (GO:0007628) | 2.59035322 |
| 80 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.57673882 |
| 81 | hippocampus development (GO:0021766) | 2.56462518 |
| 82 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.54920361 |
| 83 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.54816122 |
| 84 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.53336351 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.53020913 |
| 86 | mating behavior (GO:0007617) | 2.52019067 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.50586547 |
| 88 | proline transport (GO:0015824) | 2.50478500 |
| 89 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.50336628 |
| 90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.49910271 |
| 91 | synaptonemal complex assembly (GO:0007130) | 2.49764123 |
| 92 | regulation of respiratory system process (GO:0044065) | 2.47709255 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 2.47015786 |
| 94 | cell differentiation in hindbrain (GO:0021533) | 2.44716800 |
| 95 | cochlea development (GO:0090102) | 2.44676673 |
| 96 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.44609833 |
| 97 | regulation of neurotransmitter levels (GO:0001505) | 2.44135216 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 2.44100262 |
| 99 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.43953758 |
| 100 | cerebellar Purkinje cell layer development (GO:0021680) | 2.43703309 |
| 101 | cellular potassium ion homeostasis (GO:0030007) | 2.42718882 |
| 102 | learning (GO:0007612) | 2.41226862 |
| 103 | neuromuscular junction development (GO:0007528) | 2.40850077 |
| 104 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.40365564 |
| 105 | calcium ion-dependent exocytosis (GO:0017156) | 2.39665505 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.39258102 |
| 107 | striatum development (GO:0021756) | 2.38968440 |
| 108 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.38365644 |
| 109 | paraxial mesoderm development (GO:0048339) | 2.35425109 |
| 110 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34819335 |
| 111 | apical protein localization (GO:0045176) | 2.32560527 |
| 112 | brain morphogenesis (GO:0048854) | 2.30888327 |
| 113 | ephrin receptor signaling pathway (GO:0048013) | 2.30253528 |
| 114 | dendritic spine organization (GO:0097061) | 2.27906760 |
| 115 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.27464915 |
| 116 | mitochondrion transport along microtubule (GO:0047497) | 2.27464915 |
| 117 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.25356665 |
| 118 | synaptonemal complex organization (GO:0070193) | 2.24757897 |
| 119 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.24740543 |
| 120 | regulation of axon guidance (GO:1902667) | 2.21864327 |
| 121 | negative regulation of osteoblast proliferation (GO:0033689) | 2.21779458 |
| 122 | histone H3-K9 demethylation (GO:0033169) | 2.21703399 |
| 123 | detection of calcium ion (GO:0005513) | 2.16717047 |
| 124 | chemosensory behavior (GO:0007635) | 2.16258520 |
| 125 | convergent extension (GO:0060026) | 2.15241392 |
| 126 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.13769192 |
| 127 | cilium movement (GO:0003341) | 2.13631017 |
| 128 | nucleobase catabolic process (GO:0046113) | 2.13398024 |
| 129 | axon extension (GO:0048675) | 2.12890984 |
| 130 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.12616363 |
| 131 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.11441975 |
| 132 | regulation of establishment of planar polarity (GO:0090175) | 2.07476761 |
| 133 | mechanosensory behavior (GO:0007638) | 2.05434687 |
| 134 | negative regulation of axonogenesis (GO:0050771) | 2.04885101 |
| 135 | spinal cord development (GO:0021510) | 2.04705864 |
| 136 | nonmotile primary cilium assembly (GO:0035058) | 2.04544175 |
| 137 | axoneme assembly (GO:0035082) | 2.04475308 |
| 138 | synapsis (GO:0007129) | 2.02747274 |
| 139 | response to auditory stimulus (GO:0010996) | 2.02564117 |
| 140 | biotin metabolic process (GO:0006768) | 2.02165310 |
| 141 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.01932126 |
| 142 | epithelial cell fate commitment (GO:0072148) | 2.00928651 |
| 143 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.00673595 |
| 144 | chromosome organization involved in meiosis (GO:0070192) | 2.00669660 |
| 145 | urinary tract smooth muscle contraction (GO:0014848) | 1.95900850 |
| 146 | epithelial cilium movement (GO:0003351) | 1.95847705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.39476240 |
| 2 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88339737 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.88337964 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85334591 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82240497 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.78281535 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.76150968 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74365723 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74365723 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62970365 |
| 11 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.46753723 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.42808494 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40506081 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40441840 |
| 15 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39681774 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.38992522 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35183603 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33455307 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33260018 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32116769 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.31086964 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.30026138 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28024080 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25926849 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.16469525 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.15840181 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.06324536 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04211690 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.95126824 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.94452187 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.82184758 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78043018 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66468589 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64168901 |
| 35 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61628801 |
| 36 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.60730524 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59826510 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49760845 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46414271 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45469303 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44997770 |
| 42 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44691820 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43460301 |
| 44 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.41048630 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37320323 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36228956 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26741585 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26072655 |
| 49 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26070358 |
| 50 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.24965180 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24916789 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23605554 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22310357 |
| 54 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21760798 |
| 55 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19457003 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19198475 |
| 57 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18583811 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.18188148 |
| 59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17494291 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15870399 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14881033 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13700046 |
| 63 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12932074 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12834419 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11897247 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10107729 |
| 67 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07935878 |
| 68 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07836383 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06760192 |
| 70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05019284 |
| 71 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04522930 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04325089 |
| 73 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02392055 |
| 74 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01452491 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00735723 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00430086 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99359189 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99216135 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99216135 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98614420 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98318500 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98008247 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97983207 |
| 84 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97466196 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97142110 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96870939 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95832723 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95825462 |
| 89 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95204608 |
| 90 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95121689 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94661383 |
| 92 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93277971 |
| 93 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.93149509 |
| 94 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91874302 |
| 95 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91002003 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90505387 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90259116 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89988283 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89876535 |
| 100 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.89658183 |
| 101 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.89501864 |
| 102 | * SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.88824211 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88183692 |
| 104 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88118158 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87877240 |
| 106 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87583927 |
| 107 | TCF4_23295773_ChIP-Seq_U87_Human | 0.87567790 |
| 108 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87523954 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87487685 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85886552 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83810848 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83712290 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82966428 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82449041 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81481609 |
| 116 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81010563 |
| 117 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.80069531 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.80057526 |
| 119 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.80050864 |
| 120 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79962130 |
| 121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79495482 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77981387 |
| 123 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.76794474 |
| 124 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.75200328 |
| 125 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74502326 |
| 126 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73647222 |
| 127 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.73348520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.74589887 |
| 2 | MP0003880_abnormal_central_pattern | 3.48938064 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.12350859 |
| 4 | MP0005423_abnormal_somatic_nervous | 2.77360978 |
| 5 | MP0004270_analgesia | 2.64893621 |
| 6 | MP0009745_abnormal_behavioral_response | 2.55172443 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.44508723 |
| 8 | MP0002064_seizures | 2.42563725 |
| 9 | MP0001486_abnormal_startle_reflex | 2.39356933 |
| 10 | MP0009046_muscle_twitch | 2.35033521 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.11494194 |
| 12 | MP0000778_abnormal_nervous_system | 2.10150242 |
| 13 | MP0002272_abnormal_nervous_system | 2.03758851 |
| 14 | MP0003122_maternal_imprinting | 2.00973582 |
| 15 | MP0001968_abnormal_touch/_nociception | 1.94329815 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 1.90432552 |
| 17 | MP0004133_heterotaxia | 1.90131647 |
| 18 | MP0004145_abnormal_muscle_electrophysio | 1.78225449 |
| 19 | MP0001440_abnormal_grooming_behavior | 1.77239595 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.75209269 |
| 21 | MP0000751_myopathy | 1.74769522 |
| 22 | MP0002184_abnormal_innervation | 1.74661647 |
| 23 | MP0000566_synostosis | 1.62006941 |
| 24 | MP0000955_abnormal_spinal_cord | 1.61266340 |
| 25 | MP0004885_abnormal_endolymph | 1.59627493 |
| 26 | MP0006276_abnormal_autonomic_nervous | 1.58368097 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.57753399 |
| 28 | MP0002736_abnormal_nociception_after | 1.55934740 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.55448451 |
| 30 | MP0002822_catalepsy | 1.54419143 |
| 31 | MP0004858_abnormal_nervous_system | 1.54215512 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.53325559 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.53126278 |
| 34 | MP0001970_abnormal_pain_threshold | 1.53027436 |
| 35 | MP0002234_abnormal_pharynx_morphology | 1.48944449 |
| 36 | MP0002882_abnormal_neuron_morphology | 1.48279069 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.48267821 |
| 38 | MP0003787_abnormal_imprinting | 1.47643639 |
| 39 | MP0008569_lethality_at_weaning | 1.47184454 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.44035588 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.42068134 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.39861418 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.38982430 |
| 44 | MP0005499_abnormal_olfactory_system | 1.38982430 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.38236603 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.36724509 |
| 47 | MP0001984_abnormal_olfaction | 1.32455614 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.32407498 |
| 49 | MP0003137_abnormal_impulse_conducting | 1.29718716 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.26795797 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.26200053 |
| 52 | MP0003283_abnormal_digestive_organ | 1.26098841 |
| 53 | MP0004924_abnormal_behavior | 1.22072806 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.22072806 |
| 55 | MP0002152_abnormal_brain_morphology | 1.21535277 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.21456526 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 1.21149844 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.21061371 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.18594813 |
| 60 | MP0004142_abnormal_muscle_tone | 1.18163753 |
| 61 | MP0005410_abnormal_fertilization | 1.16264534 |
| 62 | MP0004085_abnormal_heartbeat | 1.15888772 |
| 63 | MP0008789_abnormal_olfactory_epithelium | 1.12908378 |
| 64 | MP0000516_abnormal_urinary_system | 1.12077234 |
| 65 | MP0005367_renal/urinary_system_phenotyp | 1.12077234 |
| 66 | MP0000579_abnormal_nail_morphology | 1.10709324 |
| 67 | MP0002638_abnormal_pupillary_reflex | 1.10479051 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.09778453 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.08647210 |
| 70 | MP0003329_amyloid_beta_deposits | 1.08536642 |
| 71 | MP0006292_abnormal_olfactory_placode | 1.07411559 |
| 72 | MP0000749_muscle_degeneration | 1.07051391 |
| 73 | MP0000049_abnormal_middle_ear | 1.04320429 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.03921612 |
| 75 | MP0003861_abnormal_nervous_system | 1.01420509 |
| 76 | MP0003879_abnormal_hair_cell | 1.01387952 |
| 77 | MP0000534_abnormal_ureter_morphology | 1.01267280 |
| 78 | MP0004043_abnormal_pH_regulation | 1.00450758 |
| 79 | MP0003121_genomic_imprinting | 1.00285522 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.98302962 |
| 81 | MP0003119_abnormal_digestive_system | 0.96456876 |
| 82 | MP0000537_abnormal_urethra_morphology | 0.95996954 |
| 83 | MP0005253_abnormal_eye_physiology | 0.94647751 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.94052725 |
| 85 | MP0003136_yellow_coat_color | 0.93867947 |
| 86 | MP0002233_abnormal_nose_morphology | 0.89086637 |
| 87 | MP0003942_abnormal_urinary_system | 0.88987847 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.88700672 |
| 89 | MP0002229_neurodegeneration | 0.88554860 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.86692453 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.85887860 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.85794663 |
| 93 | MP0004233_abnormal_muscle_weight | 0.84812562 |
| 94 | MP0001529_abnormal_vocalization | 0.83615534 |
| 95 | MP0003634_abnormal_glial_cell | 0.82958671 |
| 96 | MP0001905_abnormal_dopamine_level | 0.82888065 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.82546273 |
| 98 | MP0002106_abnormal_muscle_physiology | 0.82459295 |
| 99 | MP0002116_abnormal_craniofacial_bone | 0.81970758 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.81916022 |
| 101 | MP0005369_muscle_phenotype | 0.81134580 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.80820125 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.80162789 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.80035986 |
| 105 | MP0004087_abnormal_muscle_fiber | 0.79669920 |
| 106 | MP0003633_abnormal_nervous_system | 0.77979508 |
| 107 | MP0000733_abnormal_muscle_development | 0.77517057 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.77239170 |
| 109 | MP0002697_abnormal_eye_size | 0.77031013 |
| 110 | MP0003755_abnormal_palate_morphology | 0.76837053 |
| 111 | MP0003123_paternal_imprinting | 0.76367818 |
| 112 | MP0003385_abnormal_body_wall | 0.76314053 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.76260401 |
| 114 | MP0003698_abnormal_male_reproductive | 0.74722508 |
| 115 | MP0000026_abnormal_inner_ear | 0.74537888 |
| 116 | MP0000678_abnormal_parathyroid_gland | 0.74372008 |
| 117 | MP0001270_distended_abdomen | 0.74178252 |
| 118 | MP0001346_abnormal_lacrimal_gland | 0.71591078 |
| 119 | MP0003631_nervous_system_phenotype | 0.71104146 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.70811394 |
| 121 | MP0004742_abnormal_vestibular_system | 0.70717571 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.70476564 |
| 123 | MP0003938_abnormal_ear_development | 0.69788335 |
| 124 | MP0001943_abnormal_respiration | 0.68577208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.33798481 |
| 2 | Myokymia (HP:0002411) | 4.22670624 |
| 3 | Focal seizures (HP:0007359) | 4.03854166 |
| 4 | Visual hallucinations (HP:0002367) | 3.24876288 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.15301447 |
| 6 | Amblyopia (HP:0000646) | 3.01415827 |
| 7 | Abnormality of the lower motor neuron (HP:0002366) | 3.00611194 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 2.93187017 |
| 9 | Febrile seizures (HP:0002373) | 2.92668429 |
| 10 | Hand muscle atrophy (HP:0009130) | 2.75636239 |
| 11 | Atonic seizures (HP:0010819) | 2.71761954 |
| 12 | Broad distal phalanx of finger (HP:0009836) | 2.70233477 |
| 13 | Ankle clonus (HP:0011448) | 2.58354543 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.56894997 |
| 15 | Absent/shortened dynein arms (HP:0200106) | 2.56894997 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 2.54276061 |
| 17 | Hemiparesis (HP:0001269) | 2.52993592 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 2.52248515 |
| 19 | Absence seizures (HP:0002121) | 2.45815193 |
| 20 | Action tremor (HP:0002345) | 2.44221307 |
| 21 | Upper limb amyotrophy (HP:0009129) | 2.39901404 |
| 22 | Distal upper limb amyotrophy (HP:0007149) | 2.39901404 |
| 23 | Broad-based gait (HP:0002136) | 2.38679292 |
| 24 | Dysdiadochokinesis (HP:0002075) | 2.37199427 |
| 25 | Dialeptic seizures (HP:0011146) | 2.34567407 |
| 26 | Excessive salivation (HP:0003781) | 2.30517407 |
| 27 | Drooling (HP:0002307) | 2.30517407 |
| 28 | Insomnia (HP:0100785) | 2.28789863 |
| 29 | Large eyes (HP:0001090) | 2.27320962 |
| 30 | Polyphagia (HP:0002591) | 2.22334474 |
| 31 | Rimmed vacuoles (HP:0003805) | 2.22063943 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21065536 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.15973120 |
| 34 | Cutaneous finger syndactyly (HP:0010554) | 2.13811665 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 2.13042328 |
| 36 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.12823995 |
| 37 | Truncal ataxia (HP:0002078) | 2.11440364 |
| 38 | Ependymoma (HP:0002888) | 2.11294972 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 2.10302644 |
| 40 | Hyperventilation (HP:0002883) | 2.07545819 |
| 41 | Nephronophthisis (HP:0000090) | 2.05561878 |
| 42 | Depression (HP:0000716) | 2.04835542 |
| 43 | Occipital encephalocele (HP:0002085) | 2.03626311 |
| 44 | Failure to thrive in infancy (HP:0001531) | 2.02875644 |
| 45 | Myopathic facies (HP:0002058) | 2.02815231 |
| 46 | Prolonged QT interval (HP:0001657) | 1.98882197 |
| 47 | Abnormal eating behavior (HP:0100738) | 1.97600654 |
| 48 | Anxiety (HP:0000739) | 1.96245659 |
| 49 | Megalencephaly (HP:0001355) | 1.95476511 |
| 50 | Ventricular fibrillation (HP:0001663) | 1.95375846 |
| 51 | Hyperacusis (HP:0010780) | 1.92644597 |
| 52 | Poor eye contact (HP:0000817) | 1.92383967 |
| 53 | Dysmetria (HP:0001310) | 1.91422373 |
| 54 | Spastic gait (HP:0002064) | 1.91395846 |
| 55 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90768000 |
| 56 | Genetic anticipation (HP:0003743) | 1.90590699 |
| 57 | Myoglobinuria (HP:0002913) | 1.90135363 |
| 58 | Abnormality of the corticospinal tract (HP:0002492) | 1.88712693 |
| 59 | Bell-shaped thorax (HP:0001591) | 1.87716965 |
| 60 | Hypoplastic ischia (HP:0003175) | 1.86222120 |
| 61 | Abnormal EKG (HP:0003115) | 1.83219316 |
| 62 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.82476392 |
| 63 | Generalized hypotonia (HP:0001290) | 1.81702876 |
| 64 | Morphological abnormality of the middle ear (HP:0008609) | 1.81172583 |
| 65 | Hypoventilation (HP:0002791) | 1.80423737 |
| 66 | Abnormal social behavior (HP:0012433) | 1.79678990 |
| 67 | Impaired social interactions (HP:0000735) | 1.79678990 |
| 68 | Akinesia (HP:0002304) | 1.79183858 |
| 69 | Lower limb muscle weakness (HP:0007340) | 1.79147889 |
| 70 | Tubulointerstitial nephritis (HP:0001970) | 1.79066422 |
| 71 | Absent speech (HP:0001344) | 1.78908374 |
| 72 | Neoplasm of the heart (HP:0100544) | 1.78745412 |
| 73 | Abnormality of the ischium (HP:0003174) | 1.78672540 |
| 74 | Cutaneous syndactyly (HP:0012725) | 1.77658110 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 1.77201312 |
| 76 | Exercise-induced myalgia (HP:0003738) | 1.76921725 |
| 77 | Congenital glaucoma (HP:0001087) | 1.76638582 |
| 78 | Limb dystonia (HP:0002451) | 1.76138169 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 1.75242403 |
| 80 | Renal duplication (HP:0000075) | 1.75122071 |
| 81 | Bowel incontinence (HP:0002607) | 1.74894909 |
| 82 | Bronchomalacia (HP:0002780) | 1.74836876 |
| 83 | EEG with generalized epileptiform discharges (HP:0011198) | 1.74065442 |
| 84 | Neurofibrillary tangles (HP:0002185) | 1.73336630 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73255496 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 1.73255496 |
| 87 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73255496 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 1.72008433 |
| 89 | Astrocytoma (HP:0009592) | 1.71201604 |
| 90 | Abnormality of the astrocytes (HP:0100707) | 1.71201604 |
| 91 | Peripheral hypomyelination (HP:0007182) | 1.71180592 |
| 92 | Overriding aorta (HP:0002623) | 1.71063321 |
| 93 | Abnormal ciliary motility (HP:0012262) | 1.70113880 |
| 94 | Sudden death (HP:0001699) | 1.69623293 |
| 95 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69238117 |
| 96 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69238117 |
| 97 | Elfin facies (HP:0004428) | 1.69217361 |
| 98 | Turricephaly (HP:0000262) | 1.68548578 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 1.68235700 |
| 100 | Mutism (HP:0002300) | 1.67694475 |
| 101 | Hypsarrhythmia (HP:0002521) | 1.67558274 |
| 102 | Abnormality of the musculature of the hand (HP:0001421) | 1.66684026 |
| 103 | Pheochromocytoma (HP:0002666) | 1.66023643 |
| 104 | Urinary urgency (HP:0000012) | 1.65097575 |
| 105 | Abnormality of the calf musculature (HP:0001430) | 1.63759073 |
| 106 | Congenital primary aphakia (HP:0007707) | 1.63716986 |
| 107 | Sleep apnea (HP:0010535) | 1.61644197 |
| 108 | Postural instability (HP:0002172) | 1.61382710 |
| 109 | Hemiplegia (HP:0002301) | 1.60704431 |
| 110 | Impaired vibratory sensation (HP:0002495) | 1.60693585 |
| 111 | Vaginal atresia (HP:0000148) | 1.60515784 |
| 112 | Genital tract atresia (HP:0001827) | 1.59743711 |
| 113 | Abnormality of the aortic arch (HP:0012303) | 1.59232129 |
| 114 | Cholecystitis (HP:0001082) | 1.59168267 |
| 115 | Abnormal gallbladder physiology (HP:0012438) | 1.59168267 |
| 116 | Hypoplasia of the brainstem (HP:0002365) | 1.59145684 |
| 117 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.59145684 |
| 118 | Renovascular hypertension (HP:0100817) | 1.59128156 |
| 119 | Chronic hepatic failure (HP:0100626) | 1.58845768 |
| 120 | Agitation (HP:0000713) | 1.57940178 |
| 121 | Hammertoe (HP:0001765) | 1.57872840 |
| 122 | Stridor (HP:0010307) | 1.57523663 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.56498602 |
| 124 | Specific learning disability (HP:0001328) | 1.56445117 |
| 125 | Gout (HP:0001997) | 1.56435933 |
| 126 | Alacrima (HP:0000522) | 1.56301366 |
| 127 | Bifid tongue (HP:0010297) | 1.56158419 |
| 128 | Gait imbalance (HP:0002141) | 1.55211675 |
| 129 | Narrow nasal bridge (HP:0000446) | 1.55083862 |
| 130 | Retinal dysplasia (HP:0007973) | 1.54982539 |
| 131 | Type 1 muscle fiber predominance (HP:0003803) | 1.54894398 |
| 132 | Rapidly progressive (HP:0003678) | 1.54296971 |
| 133 | Difficulty climbing stairs (HP:0003551) | 1.52705081 |
| 134 | Upper limb muscle weakness (HP:0003484) | 1.51893133 |
| 135 | Shoulder girdle muscle weakness (HP:0003547) | 1.51058517 |
| 136 | Lymphangioma (HP:0100764) | 1.50871788 |
| 137 | Renal hypoplasia (HP:0000089) | 1.50515853 |
| 138 | Abnormality of dentin (HP:0010299) | 1.50148860 |
| 139 | Obstructive sleep apnea (HP:0002870) | 1.49694862 |
| 140 | Myotonia (HP:0002486) | 1.48343363 |
| 141 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.47371990 |
| 142 | Nephrogenic diabetes insipidus (HP:0009806) | 1.44806242 |
| 143 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.44513843 |
| 144 | Absent epiphyses (HP:0010577) | 1.42911739 |
| 145 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.42911739 |
| 146 | Hypoglycemic coma (HP:0001325) | 1.42710471 |
| 147 | Muscle fiber inclusion bodies (HP:0100299) | 1.42134175 |
| 148 | Hypoplasia of the iris (HP:0007676) | 1.40306162 |
| 149 | Hepatoblastoma (HP:0002884) | 1.39989192 |
| 150 | Abnormality of midbrain morphology (HP:0002418) | 1.39884358 |
| 151 | Molar tooth sign on MRI (HP:0002419) | 1.39884358 |
| 152 | Bundle branch block (HP:0011710) | 1.39696228 |
| 153 | Abnormality of permanent molar morphology (HP:0011071) | 1.39466949 |
| 154 | Abnormality of the dental root (HP:0006486) | 1.39466949 |
| 155 | Taurodontia (HP:0000679) | 1.39466949 |
| 156 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.37562864 |
| 157 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.37562864 |
| 158 | Abnormality of the labia (HP:0000058) | 1.36842282 |
| 159 | Limb-girdle muscle weakness (HP:0003325) | 1.35950700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.26201926 |
| 2 | MARK1 | 3.16111974 |
| 3 | MAP3K4 | 2.91524586 |
| 4 | EPHA4 | 2.81502081 |
| 5 | MAP3K9 | 2.56332972 |
| 6 | PRPF4B | 2.20392414 |
| 7 | MAP2K7 | 2.09990208 |
| 8 | MINK1 | 2.05768972 |
| 9 | PRKD3 | 2.04938570 |
| 10 | DAPK2 | 2.03697528 |
| 11 | NTRK2 | 1.98454456 |
| 12 | PAK6 | 1.97935874 |
| 13 | PHKG1 | 1.86114261 |
| 14 | PHKG2 | 1.86114261 |
| 15 | MAP2K4 | 1.76535007 |
| 16 | MAPK13 | 1.76256296 |
| 17 | CASK | 1.68386859 |
| 18 | PNCK | 1.62642674 |
| 19 | MAP3K2 | 1.53158831 |
| 20 | ICK | 1.49529352 |
| 21 | UHMK1 | 1.46392320 |
| 22 | SIK2 | 1.43079550 |
| 23 | PTK2B | 1.42113058 |
| 24 | BRD4 | 1.38669357 |
| 25 | MET | 1.36453444 |
| 26 | EPHA2 | 1.32274137 |
| 27 | CDK5 | 1.30767177 |
| 28 | TYRO3 | 1.27459646 |
| 29 | WNK4 | 1.26201823 |
| 30 | FRK | 1.20151897 |
| 31 | CAMK1G | 1.19629191 |
| 32 | NTRK1 | 1.19546801 |
| 33 | MUSK | 1.19372753 |
| 34 | ERBB2 | 1.17746616 |
| 35 | KSR1 | 1.15293197 |
| 36 | TNIK | 1.13646954 |
| 37 | PAK3 | 1.12207603 |
| 38 | LMTK2 | 1.11144924 |
| 39 | CDC42BPA | 1.07895472 |
| 40 | KSR2 | 1.05707947 |
| 41 | CAMKK1 | 1.05169665 |
| 42 | SGK223 | 1.04932332 |
| 43 | SGK494 | 1.04932332 |
| 44 | STK39 | 1.04810717 |
| 45 | STK11 | 0.98742561 |
| 46 | SIK1 | 0.95631193 |
| 47 | GRK5 | 0.94719940 |
| 48 | RPS6KA2 | 0.93574017 |
| 49 | PTK2 | 0.93564337 |
| 50 | TNK2 | 0.93456446 |
| 51 | STK38 | 0.93160719 |
| 52 | PRKD2 | 0.92002379 |
| 53 | PRKCG | 0.91898368 |
| 54 | WNK3 | 0.91020521 |
| 55 | WNK1 | 0.90709762 |
| 56 | PLK2 | 0.90107209 |
| 57 | DYRK1A | 0.89785675 |
| 58 | MARK2 | 0.88399739 |
| 59 | CAMK2A | 0.86971924 |
| 60 | FER | 0.85610441 |
| 61 | DAPK1 | 0.85397620 |
| 62 | CAMK1 | 0.85337300 |
| 63 | TAOK1 | 0.82408983 |
| 64 | TRIB3 | 0.81573626 |
| 65 | PRKCE | 0.81165220 |
| 66 | TTN | 0.80204105 |
| 67 | EPHB2 | 0.79418437 |
| 68 | CDK19 | 0.77811833 |
| 69 | EPHA3 | 0.76265045 |
| 70 | CAMK2G | 0.76015986 |
| 71 | PRKAA1 | 0.75572869 |
| 72 | CAMK4 | 0.74335396 |
| 73 | EEF2K | 0.73145891 |
| 74 | TESK1 | 0.72852041 |
| 75 | MAPK15 | 0.72354419 |
| 76 | OXSR1 | 0.72090547 |
| 77 | PRKCZ | 0.71190710 |
| 78 | CDK15 | 0.70979436 |
| 79 | MST1R | 0.70893459 |
| 80 | PDGFRA | 0.70310958 |
| 81 | CDK18 | 0.70072716 |
| 82 | CAMK2B | 0.68340658 |
| 83 | DYRK2 | 0.67691534 |
| 84 | MAPKAPK3 | 0.67640515 |
| 85 | SGK1 | 0.66604953 |
| 86 | LATS2 | 0.66058283 |
| 87 | FES | 0.64788569 |
| 88 | BCR | 0.64473592 |
| 89 | CDK11A | 0.62396977 |
| 90 | DDR2 | 0.61261711 |
| 91 | CDK14 | 0.60542252 |
| 92 | PRKCI | 0.59617575 |
| 93 | PRKCH | 0.59201572 |
| 94 | ERBB3 | 0.58666565 |
| 95 | CSNK1G3 | 0.57525017 |
| 96 | RPS6KA3 | 0.56704111 |
| 97 | RIPK1 | 0.55997607 |
| 98 | CAMK1D | 0.55645322 |
| 99 | ROCK1 | 0.55489829 |
| 100 | PDK4 | 0.55031809 |
| 101 | PDK3 | 0.55031809 |
| 102 | FGFR2 | 0.54789918 |
| 103 | STK38L | 0.54436853 |
| 104 | CSNK1G1 | 0.52955818 |
| 105 | ROCK2 | 0.52782722 |
| 106 | NME1 | 0.52685659 |
| 107 | CSNK1G2 | 0.52654555 |
| 108 | CAMK2D | 0.52264927 |
| 109 | SGK3 | 0.51692276 |
| 110 | FGR | 0.51578133 |
| 111 | MAP3K7 | 0.51389139 |
| 112 | MAPK10 | 0.50932047 |
| 113 | OBSCN | 0.49865430 |
| 114 | LIMK1 | 0.49004538 |
| 115 | RET | 0.48897544 |
| 116 | SGK2 | 0.46998400 |
| 117 | AKT3 | 0.46479222 |
| 118 | PRKDC | 0.46456018 |
| 119 | MAPKAPK5 | 0.46161497 |
| 120 | PKN1 | 0.46027461 |
| 121 | PINK1 | 0.45978380 |
| 122 | NEK6 | 0.45477690 |
| 123 | PDGFRB | 0.45317747 |
| 124 | ADRBK1 | 0.45130199 |
| 125 | BMX | 0.44938575 |
| 126 | MAP4K2 | 0.44282479 |
| 127 | INSRR | 0.43048530 |
| 128 | MAP2K6 | 0.42590264 |
| 129 | CSNK1E | 0.42552027 |
| 130 | MTOR | 0.40218708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.23191020 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63705642 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50744440 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.41622168 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41253467 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.32603501 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25805882 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17398290 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.16594658 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13450260 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.10504454 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98346564 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.93254020 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.88216941 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.83031487 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72132424 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72119203 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71993942 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.70569604 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66827645 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.65793620 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65043201 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55593380 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.55583989 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.52329926 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51394568 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49841037 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.48180392 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46485841 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.45460997 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.44947732 |
| 32 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.44232280 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35902103 |
| 34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28899753 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26020295 |
| 36 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.25369186 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20819547 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17417576 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16980437 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16306840 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14423900 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11559331 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.10811264 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10693882 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10536075 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08971848 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08872929 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 1.06973615 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06866066 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04671232 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03535663 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02727174 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01547913 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00973345 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00398030 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99626567 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99035864 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97520081 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97353443 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95843272 |
| 61 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.92091913 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91971672 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90499863 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89226672 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88258765 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.87891786 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86608711 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85936597 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.85681589 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84999050 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84508267 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83205809 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81509384 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79205731 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79200042 |
| 76 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.78873968 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75808543 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73225852 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68305829 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67855888 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67593179 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67522682 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67120657 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65843237 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.65828037 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65335699 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65289855 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64804301 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64331639 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63398409 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62324474 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61999933 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61977196 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61181715 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60813797 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.60666769 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60574726 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59649023 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59153535 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.59109293 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58824649 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56224389 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55140203 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54943943 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54851666 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54793782 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.54163810 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53751500 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53016919 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52713773 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51844418 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51730954 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51540703 |
| 114 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50380043 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47953319 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46993339 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46675303 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45765199 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.42649650 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39030314 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38497853 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38216476 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37125963 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36186983 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35889968 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35699166 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35384902 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35137825 |
| 129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34816036 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32926564 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32631597 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31861981 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30927234 |

